Genezen Announces the Appointment of Steven J. Favaloro as Chief Executive Officer to Support Next Phase of Growth

BOSTON and FISHERS, Ind., March 13, 2023 /PRNewswire/ — Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO) specializing in lentiviral and retroviral vector manufacturing, today announced the appointment of Steven J. Favaloro as President and Chief…

Leave a Reply

Your email address will not be published. Required fields are marked *